Auffarth Gerd

Outlook Therapeutics, Inc. · Director

Auffarth Gerd is listed in public filings as director. This Auffarth Gerd insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Outlook Therapeutics, Inc. (OTLK). Investors use Auffarth Gerd's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Outlook Therapeutics, Inc.OTLK$62k58.6k sharesGrant / ExerciseOct 3, 2025$62.2K58.6k shares$1.06--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Outlook Therapeutics, Inc.OTLK$298k286.7k sharesGrant / ExerciseOct 1, 2025$298.2K286.7k shares$1.04--
Outlook Therapeutics, Inc.OTLK$63k12.1k sharesGrant / ExerciseOct 3, 2024$63.4K12.1k shares$5.25--
Outlook Therapeutics, Inc.OTLK$296k56.6k sharesGrant / ExerciseOct 1, 2024$295.6K56.6k shares$5.22--
Outlook Therapeutics, Inc.OTLK$154k29.5k sharesGrant / ExerciseOct 1, 2024$154.0K29.5k shares$5.22--